Frontgrade Unveils RT-SADE: Precision Motor Control for Next-Gen Space Missions
19.11.2025 13:00:00 CET | Business Wire | Press Release
Frontgrade™ Technologies, a leading provider of high-reliability electronic solutions for space and national security missions, today announced the release of the RT-SADE (Radiation-Tolerant Solar Array Drive Electronics), a next-generation microprocessor-based stepper motor controller engineered to deliver precision, reliability, and versatility for demanding spacecraft and defense applications. Designed for mission-critical motion control systems such as solar array drives, RT-SADE combines radiation-tolerant electronics, advanced fault management, and flexible configuration options to give customers superior performance and confidence in the harshest environments.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251119546361/en/
Built around a microprocessor and advanced circuitry rated to 30 krad total ionizing dose, RT-SADE ensures long-term durability and mission assurance for Low- to Medium-Earth Orbit (LEO/MEO) operations. Its modular, space-qualified design supports both two-phase and three-phase motor configurations, allowing integrators to adapt a single controller across diverse spacecraft architectures, reducing design complexity, qualification costs, and development time.
For users, this translates into simplified integration, flexible system design, and faster path to flight. The RT-SADE supports both discrete digital and RS-422 serial communication, with the option to operate them simultaneously for built-in redundancy and fault tolerance, ensuring continuous operation even in the event of single-interface failure. Operators benefit from single-step precision control for simple positioning or micro-stepping down to 1/256 increments for highly accurate alignment, delivering smoother motion, greater pointing precision, and improved payload performance.
The controller’s serial telemetry interface provides real-time access to key data, including motor position, current, voltage, and temperature readings from thermistors and potentiometers. This built-in visibility allows users to monitor system health, detect anomalies early, and optimize motor performance throughout the mission. Dual watchdog subsystems and comprehensive fault management routines, including power-up and continuous background self-tests, ensure the controller remains available, even under extreme conditions, minimizing downtime and maximizing reliability.
With high-efficiency pulse-width modulation (PWM) drive circuitry, RT-SADE reduces power loss and thermal load, enabling lighter, cooler, and more efficient spacecraft power systems. Operating within –20°C to +60°C and surviving up to 15Grms vibration, it delivers consistent performance from launch to orbit. Weighing only 2.2lb (1.0kg) and drawing less than 1.5 amps at full load, it fits easily within modular open systems (MOSA) architectures, supporting both legacy and next-generation platforms across space, defense, UAV, and autonomous system applications.
“RT-SADE brings the precision and fault-tolerant performance our customers expect from Frontgrade, in a compact, flexible package ready for the next era of mission design,” said Lorne Graves, Senior Vice President and Chief Technology Officer at Frontgrade Technologies. “By combining radiation-tolerant engineering with intelligent control and built-in redundancy, we’re helping customers achieve higher mission assurance with less complexity and risk.”
With the introduction of RT-SADE, Frontgrade reinforces its commitment to delivering space-proven, high-reliability electronics that enable customers to operate smarter, safer, and longer, wherever their missions go. Learn more about Frontgrade’s RT-SADE.
About Frontgrade™
Frontgrade Technologies builds mission-critical electronics and electromechanical products for space, aerospace, and defense. With over 60 years of space flight heritage, the portfolio includes high-reliability components, subsystems, and assemblies engineered for performance and built for speed. Proven in operation, these technologies support complex missions across air, land, sea, space, and cyber, and perform reliably in the world’s most demanding environments. From RF and microwave technologies to motion control, power, and processing, Frontgrade delivers the innovation, precision, and execution today’s missions demand. Learn more at www.frontgrade.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20251119546361/en/
Contacts
For Media Inquiries Contact
Frontgrade Technologies
press@frontgrade.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release
inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom